Los Angeles Capital Management
MYGN icon

Los Angeles Capital Management’s Myriad Genetics MYGN Stock Holding History

Los Angeles Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Sell
87,180
-10,239
-11% -$53.3K ﹤0.01% 948
2025
Q4 		$774K Buy
97,419
+16,023
+20% +$116K ﹤0.01% 736
2025
Q3 		$588K Buy
+81,396
New +$483K ﹤0.01% 875
2019
Q3 		– Sell
-39,803
Closed -$1.11M – 1332
2019
Q2 		$1.11M Sell
39,803
-18,770
-32% -$530K 0.01% 818
2019
Q1 		$1.95M Sell
58,573
-7,280
-11% -$222K 0.01% 662
2018
Q4 		$1.91M Buy
65,853
+6,445
+11% +$232K 0.01% 565
2018
Q3 		$2.73M Buy
59,408
+41,908
+239% +$1.86M 0.01% 586
2018
Q2 		$654K Sell
17,500
-8,390
-32% -$283K ﹤0.01% 1056
2018
Q1 		$765K Buy
25,890
+20,050
+343% +$678K ﹤0.01% 904
2017
Q4 		$201K Buy
+5,840
New +$197K ﹤0.01% 1272
2014
Q1 		– Sell
-18,041
Closed -$379K – 1291
2013
Q4 		$379K Buy
+18,041
New +$456K ﹤0.01% 1008

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return